SeaStar Medical Holding Corp
ICUCW0.011USD
-0.001-7.08%
Close （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
SeaStar Medical Holding Corp Info
Ticker SymbolICUCW
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
CEOMr. Eric Schlorff
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Ticker SymbolICUCW
IPO dateJan 26, 2021
CEOMr. Eric Schlorff
Company Executives of SeaStar Medical Holding Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
--
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
--
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 2
Updated: Fri, Jan 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
32
1.38M
0.00%
-1.20M
2025Q3
31
1.35M
0.00%
-1.47M
2025Q2
35
1.65M
0.00%
-1.82M
2025Q1
36
1.65M
0.00%
-1.84M
2024Q4
40
1.61M
0.00%
-1.96M
2024Q3
48
1.73M
0.00%
-2.82M
2024Q2
49
1.82M
0.00%
-2.85M
2024Q1
48
1.89M
0.00%
-3.04M
2023Q4
48
2.81M
0.00%
-2.65M
2023Q3
47
3.81M
0.00%
-1.48M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Virtu Americas LLC
42.03K
0%
+42.03K
--
Sep 30, 2025
Skyview Investment Advisors, LLC
64.66K
0%
--
--
Jun 30, 2025
Boothbay Fund Management, LLC
245.20K
0%
--
--
Sep 30, 2025
ATW Spac Management LLC
245.20K
0%
--
--
Sep 30, 2025
Linden Advisors L.P.
218.07K
0%
--
--
Sep 30, 2025
Goldman Sachs & Company, Inc.
211.38K
0%
--
--
Sep 30, 2025
LMR Partners LLP
125.00K
0%
--
--
Sep 30, 2025
Equitec Proprietary Markets, LLC
35.70K
0%
-44.70K
-55.60%
Sep 30, 2025
Clear Street LLC
46.69K
0%
-404.00
-0.86%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of SeaStar Medical Holding Corp?
The top five shareholders of SeaStar Medical Holding Corp are:
Virtu Americas LLC holds 42.03K shares, accounting for 0.00% of the total shares.
Skyview Investment Advisors, LLC holds 64.66K shares, accounting for 0.00% of the total shares.
Boothbay Fund Management, LLC holds 245.20K shares, accounting for 0.00% of the total shares.
ATW Spac Management LLC holds 245.20K shares, accounting for 0.00% of the total shares.
Linden Advisors L.P. holds 218.07K shares, accounting for 0.00% of the total shares.
Virtu Americas LLC holds 42.03K shares, accounting for 0.00% of the total shares.
Skyview Investment Advisors, LLC holds 64.66K shares, accounting for 0.00% of the total shares.
Boothbay Fund Management, LLC holds 245.20K shares, accounting for 0.00% of the total shares.
ATW Spac Management LLC holds 245.20K shares, accounting for 0.00% of the total shares.
Linden Advisors L.P. holds 218.07K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of SeaStar Medical Holding Corp?
The top three shareholder types of SeaStar Medical Holding Corp are:
Other
Other
How many institutions hold shares of SeaStar Medical Holding Corp (ICUCW)?
As of 2025Q4, 32 institutions hold shares of SeaStar Medical Holding Corp, with a combined market value of approximately 1.38M, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for SeaStar Medical Holding Corp?
In --, the -- business generated the highest revenue for SeaStar Medical Holding Corp, amounting to -- and accounting for --% of total revenue.
